Trial
NCT01705652
Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Prostate Cancer
Intervention
Nexrutine
Why stopped
loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-11